J. Hetzel

Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial

Athol U. Wells, Kevin R. Flaherty, Kevin K. Brown et al. · The Lancet Respiratory Medicine · 2020 · 522 citations · Full text

Inbuild Trial, Parallel-group Trial, Advanced Lung Disease +5

HRCT-features of Pneumocystis jiroveci pneumonia and their evolution before and after treatment in non-HIV immunocompromised patients

Monika Vogel, M. Vatlach, Patrick Weissgerber et al. · European Journal of Radiology · 2011 · 90 citations

Non-hiv Immunocompromised Patients, Pneumocystis Jiroveci Pneumonia, Pathology +4

Accuracy of serum LDH elevation for the diagnosis of Pneumocystis jiroveci pneumonia

MN Vogel, Patrick Weissgerber, Benjamin Goeppert et al. · Swiss Medical Weekly · 2011 · 50 citations · Full text

Primary Immunodeficiency, Medical Diagnostics, Pcp Patients +13

Humane metapneumovirus (HMPV) associated pulmonary infections in immunocompromised adults—Initial CT findings, disease course and comparison to respiratory-syncytial-virus (RSV) induced pulmonary infections

Roland Syha, Robert Beck, J. Hetzel et al. · European Journal of Radiology · 2012 · 44 citations

Respiratory Virus Immunity, Pulmonary Infections, Respiratory Diseases +8

Pulmonary Hemodynamics in Obstructive Sleep Apnea: Frequency and Causes of Pulmonary Hypertension

M Hetzel, Matthias Kochs, Nikolaus Marx et al. · Lung · 2003 · 42 citations

Sleep, Hypertension, Pulmonary Arterial Hypertension +12